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Tryptamine alkaloids such as serotonin2) (1a, Chart 1), N-
methylserotonin3) (1b), bufotenine4a,b) (1c), 5-methoxy-N-
methyltryptamine5) (2a), and melatonin6) (2b) have marked
physiological effects in spite of their simple chemical struc-
tures. Members of the alkaloid family are still increasing,
thus bufobutanoic acid7) (3a) and N-(indol-3-yl)methyl-5-
methoxy-N-methyltryptamine8) (4, Chart 2) have recently
been isolated from Ch’an Su and the roots of Antirhea lucida
(Sw.) HOOK (Rubiaceae), respectively. Lespedamine9) (5,
Chart 4) is an alkaloid isolated from Lespedeza bicolor var.
japonica NAKAI.
From the viewpoint of developing novel biologically active
substances, the tryptamine alkaloids seem to be attractive tar-
get compounds. Although synthetic methods for 1a—c2—4)
and 2a,b6) have already been established, they require many
steps starting from expensive indoles having an oxygen func-
tional group at the 5-position. In the case of 5, the unique 1-
methoxyindole structure required chemists to devise an inge-
nious synthesis.10) Generally speaking, the above syntheses
are complex compared to the simple structures of the target
compounds. How to prepare a simple target in a simple way
is the most challenging ongoing subject in our group.
We have proposed 1-hydroxyindole hypotheses,11) which
could unify the biogenesis of many indole alkaloids by as-
suming 1-hydroxytryptamines (or 1-hydroxytryptophans) as
common intermediates. In order to verify these hypotheses,
we have created synthetic methods for the previously un-
known 1-hydroxytryptamines.12) We have also realized un-
precedented nucleophilic substitution reactions in indole
chemistry,13) which had been predicted in the hypotheses.11)
These findings were successfully applied to two simple syn-
thetic routes to melatonin1) (2b), starting from 6b and 6d
through 8b and 8d, respectively. The present paper is a full
report of the previous communications14) and describes fur-
ther applications of the above findings to novel and simple
syntheses of 1a—c, 2a, 3a, 4, and 5 from tryptamine (6c).
An alternative synthesis of 5 through 1-methoxy-2-oxindole
derivatives is also reported.
Syntheses of 1a, 1b, and 1c Syntheses of 1a—c were
achieved as follows. First, N-methoxycarbonyltryptamine
(6d), readily and quantitatively available from 6c by a con-
ventional method, was converted to 7d by reduction with tri-
ethylsilane15) (Et3SiH) in CF3COOH (TFA) in 97% yield.
1)
Next, our 1-hydroxyindole synthetic method,12) employing
30% hydrogen peroxide (H2O2) in the presence of sodium
tungstate dihydrate (Na2WO4·2H2O) as a catalyst, was ap-
plied to 7d to produce a 67% yield of 1-hydroxy-N-methoxy-
carbonyltryptamine1) (8d), a potent inhibitor of blood platelet
aggregation.16) However, an attempt to obtain 8a from 7a by
the 1-hydroxyindole synthetic method was unsuccessful be-
cause of the unstable nature of 8a.
The desired regioselective nucleophilic hydroxylation at
the 5-position was realized by reacting 8d with 85% formic
acid (HCOOH) at room temperature for 14 h to afford 9a and
9b in 54 and 8% yields, respectively. In the same reaction,
when the reaction time was shortened to 20 min, 9b and the
corresponding 5-formyloxy compound (9c) were obtained in
24 and 40% yields, respectively. These observations suggest
that formate is the initially introduced nucleophile into the 5-
position. Subsequent treatment with 8% HCl in MeOH con-
verted 9c into 9b in 60% yield.
Selective formation of 9a in 69% yield was achieved upon
treatment with 85% HCOOH at 80 °C when 1-methoxy de-
rivative17) (10) was employed as a substrate, prepared by
methylation of 8d with diazomethane (CH2N2). As in the
case of 8d, 10 afforded 9b and 9c in 25 and 38% yields, re-
spectively, upon reaction with 85% HCOOH at room temper-
ature with a short reaction time (15 min). Interconversions
between 9a and 9b were readily carried out. Thus, treatment
of 9b with 85% HCOOH at room temperature for 48 h af-
forded 9a in 69% yield, while alkaline hydrolysis of 9a with
8% NaOH in MeOH gave 9b in 76% yield. Subsequent hy-
drolysis of 9b to 1a proceeded in 73% yield by treatment
with 10% NaOH in refluxing MeOH,12c) while reduction of
9b with lithium aluminium hydride (LiAlH4) in refluxing
Et2O–THF afforded 1b in 65% yield. Consequently, 1a and
1b are now available in five steps from 6c in 26 and 23%
overall yields, respectively. Since both the 1-hydroxyindole
synthesis and nucleophilic substitution steps are our original
reactions, the originality rates18) of 1a and 1b are the same
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(50%).
As long as 85% HCOOH was used, attempts to obtain 1c
were unsuccessful under various reaction conditions, starting
from 1-hydroxy-N,N-dimethyltryptamine (8e) which was
prepared from 6c through 6e17) and 7e17) in 51% overall
yield. However, more acidic condition such as 5% aqueous
H2SO4 at reflux was found to convert 8e into 1c
4c) in 47%
yield together with 16% yield of dehydroxylated product
(6e). If the solvent was changed to MeOH under similar con-
ditions, 8e afforded 2e, 1c, and 6e in 57, 7, and 11% yields,
respectively. Comparing the 1H-NMR spectrum of 2e with
those of the corresponding 1-acetyl (11a) and 1-formyl de-
rivative (11b), an anisotropy effect of the 1-acyl group on the
C-7 proton was observed by about 1 ppm. This clearly proved
their structures. Subsequent cleavage of the methoxy group
of 2e with boron tribromide (BBr3) in CH2Cl2–toluene re-
sulted in an alternative route to 1c in 63% yield. As a result,
1c is available from 6c in four steps in 24% overall yield with
60% originality rate.18)
Synthesis of 3a Total synthesis of 3a was achieved by
three different routes by applying above results. The first
route employed 9a as an intermediate. The reaction of 9a
with benzyl bromide in the presence of K2CO3 in N,N-di-
methylformamide (DMF) afforded 12a in 94% yield. Alka-
line hydrolysis of 12a with 10% NaOH in refluxing MeOH
provided a 96% yield of 5-benzyloxytryptamine (12b).19)
With 12b, a useful building block for preparing various sero-
tonin derivatives in hand, we converted it to 3b in 96% yield
by reaction with succinic anhydride in THF. Confirmation of
the carboxyl group in 3b was shown by conversion to ester
compound (3d) in 97% yield by methylation with CH2N2 at
0 °C. However, when the same methylation was carried out at
room temperature, the yield of 3d decreased to 57% and for-
mation of the corresponding succinimide (13a) was observed
in 30% yield. Finally, catalytic hydrogenation of 3b over 10%
Pd/C afforded 3a in 99% yield. The spectroscopic data were
identical with those reported in the literature.8) Consequently,
the first synthesis of 3a was achieved in eight steps from 6c
in 25% overall yield with a 33% originality rate.
For the second route, a six-step synthesis of 3a from 6c in
13% overall yield with 43% originality rate was developed as
follows. Compound 6c was initially reacted with succinic an-
hydride in THF, followed by methylation with CH2N2 in a
one pot procedure, to give methyl N-[2-(indol-3-yl)ethyl]suc-
cinamate (14) and N-[2-(indol-3-yl)ethyl]succinimide (13b)
in 89 and 3% yields, respectively. Reduction of 14 with
Et3SiH in TFA provided the corresponding 2,3-dihydroindole
(15) in 99% yield. Application of our 1-hydroxyindole syn-
thetic method with Na2WO4·2H2O–30% H2O2 to 15 pro-
duced the desired 1-hydroxytryptamine (16) in 56% yield.
Introduction of hydroxy group into the 5-position of 16 was
achieved by treatment with 85% HCOOH to afford serotonin
derivative (3c) in 38% yield together with a 21% yield of the
corresponding 1-formyl compound (3e). Finally, the ester
part of 3c was hydrolyzed with 7% K2CO3 in MeOH at 50 °C
to provide 3a in 70% yield, though when the reaction was
carried out at room temperature, 13c was formed as a major
product.
For the third route, 1a was used as an intermediate. Al-
though 1a is known to react with acylating reagents at both
side chain nitrogen and phenolic oxygen atoms,20,21) we ex-
amined reaction conditions of 1a with methyl chloroformate
thoroughly and found that DMF is the solvent of choice to
realize selective N-acylation to provide 9b20) in 94% yield.
Based on this finding, 1a was allowed to react with succinic
anhydride in DMF at room temperature to afford 3a in 84%
yield without formation of the product derived from reaction
at the phenolic oxygen atom. Thus, another six-step synthesis
of 3a from 6c in 17% overall yield with 57% originality rate
was developed.
Synthesis of 4 and 2a Total synthesis of 4 was achieved
by the following two routes (Chart 2). Our alkylation method
for gramine22) (17) with nucleophiles using tri-n-butylphos-
phine (Bu3P) as a catalyst was successfully applied to 6a in
refluxing acetonitrile (MeCN) resulting in the formation of
18 in 73% yield. Next, preparation of 19a was achieved in
71% yield when reduction of 18 was carried out with sodium
cyanoborohydride23) in AcOH–TFA (3 : 1, v/v). Interestingly,
the use of AcOH alone as a solvent was not effective and led
to the formation of 19a, 19b, and unreacted 18 in 28, 11, and
60% yields, respectively. The structure of 19a was readily
confirmed by its 1H-NMR spectrum in which the methylene
protons, connected to both the nitrogen atom and indole nu-
cleus, were observed as a sharp AB quartet with a coupling
constant of 13.4 Hz.
Selective reduction of the indole ring having a 2-
aminoethyl side chain can be explained as shown in Chart 3.
Generally, reduction of indole requires protonation at the 3-
position and the resultant iminium carbon atom at the 2-posi-
tion is attacked by hydride. In the case of 18, rapid protona-
tion initially occurs on the side chain basic nitrogen atom
leading to an ammonium salt (18A). The slow second proto-
nation can occur either at the 3- or 39-positions, generating
18B or 18C, respectively. Formation of 18B would be how-
ever energetically more favorable than 18C, because the 3
position is further from the positively charged nitrogen atom
than the 39 position. Consequently the second proton ap-
proaching to the 3 position experiences less electrostatic re-
pulsion.
Application of the 1-hydroxyindole synthetic method with
Na2WO4·2H2O–30% H2O2 to 19a gave the corresponding 1-
hydroxyindole derivative (20) in 51% yield. Subsequent re-
gioselective methoxylation of 20 by treatment with 10%
H2SO4 in MeOH proceeded in 19% yield resulting in the first
six-step total synthesis of 424) from 6c in 5% overall yield
with 57% originality rate.
An alternative eight-step synthesis of 4 from 6c in 24%
overall yield with 44% originality rate is the following. Re-
duction of 6f with Et3SiH–TFA afforded 7f in 95% yield. Ox-
idation of 7f with Na2WO4·2H2O–30% H2O2 produced 1-hy-
droxy-N-methoxycarbonyl-N-methyltryptamine (8f) in 76%
yield. Then, treatment of 8f with 5% H2SO4 in refluxing
MeOH gave 2f in 48% yield. Hydrolysis of 2f with 40%
NaOH in refluxing MeOH afforded a 93% yield of 2a, which
is known as an alkaloid isolated from reed canary grass
(Phalaris arundinacea L.).5) Finally, our Bu3P catalyzed re-
action of 17 with 2a in refluxing MeCN provided 4 in 78%
yield.
Synthesis of 5 The first total synthesis of 5 by Acheson
and co-workers10) was carried out in thirteen steps from 2-ni-
troaniline (21) via such intermediates as 22 and 23 in 2.6%
overall yield. We needed a simpler synthesis of 5 in order to




begin a study of its derivatives and their biological activity.
We have developed two synthetic routes to 5. The first one
is the simplest among the thus far reported syntheses.10,25)
Methylation of 8e, obtained from 6c in three steps, as de-
scribed above, with CH2N2 resulted in 5 in 57% yield. Thus,
5 is now available in four steps from 6c in 29% overall yield
with 40% originality rate.
Interestingly, when the oxidation of 7e with Na2WO4·
2H2O–30% H2O2 and subsequent treatment with CH2N2 were
performed in a one pot procedure, lespedamine N-oxide
(24a) was obtained in 31% yield together with a 26% yield
of 5. Isolation of 24a suggested the presence of the corre-
sponding 1-hydroxy compound (24b) in the reaction mixture
of the oxidation step. All attempts to isolate 24b immediately
after oxidation of 7e failed due to its unstable nature.
To confirm the structure of 5 by an alternative synthesis,
we established a second route starting from methyl 2-nitro-
phenylacetate (25).14a) Thus, treatment of 25 with zinc (Zn,
20 eq) and ammonium chloride (NH4Cl) in MeOH for 3 h af-
forded 26 in 48% yield. When an excess amount of Zn was
used or when a longer reaction time was employed, the yield
of 26 decreased and a significant amount of 26 was con-
sumed to form a Zn–complex (27). Based on its mass spec-
tral data, the ratio of oxindole moiety to zinc in the complex
was found to be 2 to 1. In addition, treatment of 27 with ei-
ther Ac2O–pyridine or CH2N2 afforded a good yield of 1-ace-
toxy- (28) or 1-methoxy-2-oxindole25) (29), respectively,
proving the structure of 27. Applying these observations, di-
rect preparation methods for 28 and 29 in 70 and 77% yields,
respectively, were established by treating the reaction prod-
ucts (a mixture of 26 and 27), obtained after reduction of 25
with Zn–NH4Cl, with either Ac2O–pyridine or CH2N2. Hy-
drolysis of 28 with aq. Na2CO3 gave 26 in 94% yield.
With 29 in hand, it was allowed to react with ethylene di-
bromide in the presence of sodium hydride to afford a spiro
compound (30) in 90% yield. Nucleophilic attack on the cy-
clopropane ring in 30 with aqueous dimethyl amine and its
hydrochloride in DMF led to 1-methoxy-3-(2-N,N-dimethy-
laminoethyl)-2-oxindole (31) in 54% yield together with a
10% yield of the indole ring cleavage product (32). Subse-
quent reduction of 31 with LiAlH4 in ether produced 2,3-di-
hydro-2-hydroxy-1-methoxyindole (33) in 62% yield as a
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mixture of diastereoisomers, which was found to be quite
sensitive to acids. Thus, upon treatment with aq. HCl, 33 in-
stantaneously collapsed to 5 in 95% yield. Based on this re-
sult, work-up of the reduction step was improved as follows.
After reduction of 31 with LiAlH4, the reaction mixture was
treated briefly with aq. HCl. By this modification, 5 was pre-
pared in 64% yield directly from 31. As a result, the total
synthesis of 5 was achieved in five steps with 24% overall
yield from 25.
In conclusion, we have reported that nucleophilic substitu-
tion reaction13) of 1-hydroxytryptamines12) can be utilized as
a common and simple methodology for the preparations of
serotonin congeners. Investigations of the scope and limita-
tions of applicable nucleophiles for the substitution reaction
are in progress.
Experimental
Melting points were determined on a Yanagimoto micro melting point ap-
paratus and are uncorrected. IR spectra were determined with a Shimadzu
IR-420 spectrophotometer, and 1H-NMR spectra with a JEOL JNM PMX60,
JEOL JNM FX100S, or JEOL GSX-500 spectrometer with tetramethylsilane
as an internal standard. MS spectra were recorded on a JEOL SX-102A
spectrometer. Column chromatography was performed on silica gel (SiO2,
100—200 mesh, from Kanto Chemical Co. Inc.) or activated alumina
(Al2O3, 300 mesh, from Wako Pure Chemical Industries, Ltd.). Preparative
thin layer chromatography (p-TLC) was performed on Merck Kieselgel
GF254 (type 60) (SiO2).
N-Methyltryptamine (6a) from N-Methoxycarbonyltryptamine (6d)
LiAlH4 (678.0 mg, 17.9 mmol) was added to a solution of 6d (1.241 g,
5.69 mmol) in anhydrous THF (20.0 ml) and the mixture was refluxed for 4 h
with stirring. After cooling, MeOH was added to the reaction mixture to de-
stroy excess LiAlH4 and then 10% aq. Rochelle salt was added. The whole
was extracted with EtOAc and the extract was washed with brine, dried over
Na2SO4, and evaporated under reduced pressure to leave an oil, which was
column-chromatographed on SiO2 with CHCl3–MeOH–28% aq. NH3 (46 :
5 : 0.5, v/v) to give 6a (932.1 mg, 94%). 6a: mp 90—91 °C (colorless prisms,
recrystallized from EtOAc–hexane). IR (KBr): 3300, 3130, 1618,
1450 cm21. 1H-NMR (CDCl3) d : 1.60 (1H, br s, disappeared on addition of
D2O), 2.44 (3H, s), 2.92 (2H, t, J56.6 Hz), 2.98 (2H, t, J56.6 Hz), 7.03 (1H,
d, J52 Hz, collapsed to s on addition of D2O), 7.12 (1H, br t, J58.1 Hz),
7.19 (1H, br t, J58.1 Hz), 7.36 (1H, dt, J58.1, 1 Hz), 7.63 (1H, br d,
J58.1 Hz), 8.19 (1H, br s, disappeared on addition of D2O). MS m/z: 174
(M1). Anal. Calcd for C11H14N2: C, 75.82; H, 8.10; N, 16.08. Found: C,
75.58; H, 8.24; N, 16.02.
N-Methoxycarbonyl-N-methyltryptamine (6f) from 6a A solution of
ClCOOMe (320.3 mg, 3.4 mmol) in CHCl3 (1.0 ml) was added to a solution
of 6a (188.5 mg, 1.1 mmol) in CHCl3 (2.0 ml). To the resultant solution was
added Et3N (0.4 ml) at 0 °C with stirring. After additional stirring at room
temperature for 23 h, sat. aq. NaHCO3 was added to the reaction mixture and
the whole was extracted with CHCl3. The extract was washed with brine,
dried over Na2SO4, and evaporated under reduced pressure to leave an oil,
which was column-chromatographed on SiO2 with EtOAc–hexane (1 : 1,
v/v) to give 6f (250.6 mg, 99%). 6f: mp 88—89 °C (colorless prisms, recrys-
tallized from MeOH). IR (KBr): 3270, 1672 cm21. 1H-NMR (DMSO-d6,
60 °C) d : 2.82 (3H, s), 2.89 (2H, dt, J50.7, 7.6 Hz), 3.47 (2H, t, J57.6 Hz),
3.55 (3H, br s), 6.98 (1H, ddd, J57.8, 7, 1 Hz), 7.06 (1H, ddd, J58.1, 7,
1 Hz), 7.10 (1H, d, J52.2 Hz), 7.33 (1H, dt, J58.1, 1 Hz), 7.53 (1H, d, J5
7.8 Hz), 10.66 (1H, br s, disappeared on addition of D2O). MS m/z: 232
(M1). Anal. Calcd for C13H16N2O2: C, 67.22; H, 6.94; N, 12.06. Found: C,
67.30; H, 6.94; N, 12.07.
2,3-Dihydro-N,N-dimethyltryptamine (7e) from N,N-Dimethyltrypta-
mine (6e) Et3SiH (0.51 ml, 3.19 mmol) was added to a solution of 6e
(201.4 mg, 1.07 mmol) in TFA (20.0 ml) and the mixture was stirred at 55 °C
for 2 h. After evaporation of the solvent under reduced pressure, the residual
oil was made basic (pH 11) by adding 8% NaOH and the whole was ex-
tracted with CH2Cl2–MeOH (95 : 5, v/v). The extract was washed with brine,
dried over Na2SO4, and evaporated under reduced pressure to leave an oil,
which was column-chromatographed on SiO2 with CHCl3–MeOH–28% aq.
NH3 (46 : 5 : 0.5, v/v) to give 7e (189.4 mg, 93%). 7e: Colorless viscous oil.
IR (film): 1610, 1488, 1465, 747 cm21. 1H-NMR (CDCl3) d : 1.68—1.75
(1H, m), 1.98—2.04 (1H, m), 2.25 (6H, s), 2.30—2.43 (2H, m), 3.21 (1H,
dd, J58.6, 7.5 Hz), 3.28—3.34 (1H, m), 3.69 (1H, t, J58.6 Hz), 3.72 (1H,
br s, disappeared on addition of D2O), 6.64 (1H, d, J57.7 Hz), 6.72 (1H, dt,
J50.9, 7.7 Hz), 7.03 (1H, br t, J57.7 Hz), 7.10 (1H, d, J57.7 Hz). HR-MS
m/z: Calcd for C12H18N2: 190.1469. Found: 190.1478.
2,3-Dihydro-N-methoxycarbonyl-N-methyltryptamine (7f) from 6f
Et3SiH (1.40 ml, 8.8 mmol) was added to a solution of 6f (681.8 mg,
2.94 mmol) in TFA (10.0 ml) and the mixture was stirred at 70 °C for 4 h.
After evaporation of the solvent under reduced pressure, the residual oil was
made basic (pH 10) by adding 30% aq. NaOH and the whole was extracted
with EtOAc. The extract was washed with brine, dried over Na2SO4, and
evaporated under reduced pressure to leave an oil, which was column-chro-
matographed on SiO2 with EtOAc–hexane (1 : 1, v/v) to give 7f (652.2 mg,
95%). 7f: Colorless viscous oil. IR (film): 3350, 1686 (br) cm21. 1H-NMR
(DMSO-d6, 90 °C) d : 1.61—1.69 (1H, m), 1.89—1.97 (1H, m), 2.83 (3H, s),
3.08—3.16 (2H, m), 3.25 (1H, ddd, J513.9, 8.6, 5.4 Hz), 3.33 (1H, ddd,
J513.9, 8.8, 6.4 Hz), 3.52—3.60 (1H, m), 3.59 (3H, s), 5.14 (1H, br s, dis-
appeared on addition of D2O), 6.48 (1H, br d, J57.6 Hz), 6.53 (1H, dt, J51,
7.3 Hz), 6.89 (1H, dddd, J57.6, 7.3, 1, 0.5 Hz), 7.02 (1H, br d, J57.3 Hz).
HR-MS m/z: Calcd for C13H18N2O2: 234.1368. Found: 234.1365.
2,3-Dihydro-N-methyltryptamine (7a) from 6a Et3SiH (0.12 ml,
0.75 mmol) was added to a solution of 6a (43.2 mg, 0.25 mmol) in TFA
(2.0 ml) and the mixture was stirred at 60 °C for 4 h. After evaporation of the
solvent under reduced pressure, the residual oil was made basic (pH 10) by
adding 8% aq. NaOH and the whole was extracted with EtOAc. The extract
was washed with brine, dried over Na2SO4, and evaporated under reduced
pressure to leave an oil, which was column-chromatographed on SiO2 with
CHCl3–MeOH–28% aq. NH3 (46 : 5 : 0.5, v/v) to give 7a (38.2 mg, 87%).
7a: Colorless oil. IR (film): 3300 (br), 1607 cm21. 1H-NMR (CDCl3) d :
1.55—1.95 (2H, m, disappeared on addition of D2O), 1.70—1.79 (1H, m),
1.99—2.08 (1H, m), 2.46 (3H, s), 2.63—2.73 (2H, m), 3.23 (1H, dd, J58.8,
7.3 Hz), 3.30—3.38 (1H, m), 3.69 (1H, t, J58.8 Hz), 6.65 (1H, d, J5
7.3 Hz), 6.73 (1H, dt, J51, 7.3 Hz), 7.03 (1H, br t, J57.3 Hz), 7.09 (1H, d,
J57.3 Hz). HR-MS m/z: Calcd for C11H16N2: 176.1313. Found: 176.1313.
1-Hydroxy-N,N-dimethyltryptamine (8e) from 7e A solution of
Na2WO4·2H2O (132.5 mg, 0.40 mmol) in H2O (4.0 ml) was added to a solu-
tion of 7e (378.9 mg, 1.98 mmol) in MeOH (40.0 ml). To the resultant solu-
tion was added 30% H2O2 (2.0 ml, 19.6 mmol) at 0 °C with stirring. After
stirring at room temperature for 20 min, H2O was added to the reaction mix-
ture and the whole was extracted with CH2Cl2–MeOH (95 : 5, v/v). The ex-
tract was washed with brine, dried over Na2SO4, and evaporated under re-
duced pressure to leave an oil, which was column-chromatographed on SiO2
with CHCl3–MeOH–28% aq. NH3 (46 : 5 : 0.5, v/v) to give unreacted 7e
(19.1 mg, 5%) and 8e (223.5 mg, 55%) in the order of elution. 8e: mp
179.5—180.0 °C (colorless needles, recrystallized from MeOH–H2O). IR
(KBr): 1470, 1320, 840, 737 cm21. 1H-NMR (CD3OD) d : 2.35 (6H, s),
2.64—2.68 (2H, m), 2.89—2.93 (2H, m), 6.99 (1H, ddd, J58.1, 7.5,
0.9 Hz), 7.09 (1H, s), 7.13 (1H, ddd, J58.1, 7.5, 0.9 Hz), 7.34 (1H, dt,
J58.1, 0.9 Hz), 7.50 (1H, dt, J58.1, 0.9 Hz). MS m/z: 204 (M1). Anal.
Calcd for C12H16N2O: C, 70.56; H, 7.90; N, 13.71. Found: C, 70.35; H, 8.04;
N, 13.66.
1-Hydroxy-N-methoxycarbonyl-N-methyltryptamine (8f) from 7f A
solution of Na2WO4·2H2O (20.6 mg, 0.06 mmol) in H2O (0.5 ml) was added
to a solution of 7f (55.9 mg, 0.24 mmol) in MeOH (5.0 ml). To the resultant
solution was added 30% H2O2 (0.25 ml, 2.5 mmol) at 0 °C with stirring.
After stirring at room temperature for 40 min, H2O was added to the reaction
mixture and the whole was extracted with CHCl3. The extract was washed
with brine, dried over Na2SO4, and evaporated under reduced pressure to
leave an oil, which was column-chromatographed on SiO2 with EtOAc–
hexane (1 : 1, v/v) to give 8f (45.0 mg, 76%). 8f: mp 107—108 °C (colorless
prisms, recrystallized from Et2O–hexane). IR (KBr): 3160, 1662,
1492 cm21. 1H-NMR (DMSO-d6, 90 °C) d : 2.82 (3H, s), 2.88 (2H, dt,
J50.7, 7.6 Hz), 3.47 (2H, t, J57.6 Hz), 3.56 (3H, s), 6.98 (1H, ddd, J58.1,
7.1, 1 Hz), 7.12 (1H, ddd, J58.1, 7.1, 1 Hz), 7.16 (1H, s), 7.32 (1H, d,
J58.1 Hz), 7.52 (1H, d, J58.1 Hz), 10.76 (1H, s, disappeared on addition of
D2O). MS m/z: 248 (M
1). Anal. Calcd for C13H16N2O3: C, 62.89; H, 6.50; N,
11.28. Found: C, 62.98; H, 6.54; N, 11.22.
5-Hydroxy- (9b) and 1-Formyl-5-hydroxy-N-methoxycarbonyltrypta-
mine (9a) from 1-Hydroxy-N-methoxycarbonyltryptamine (8d) A solu-
tion of 8d (49.5 mg, 0.21 mmol) in 85% HCOOH (5.0 ml) was stirred at
room temperature for 14 h. After evaporation of the solvent under reduced
pressure, H2O was added to the residue under ice cooling. The whole was
extracted with CH2Cl2–MeOH (95 : 5, v/v). The extract was washed with
brine, dried over Na2SO4, and evaporated under reduced pressure to leave an
oil, which was column-chromatographed on SiO2 with CHCl3–MeOH–28%
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aq. NH3 (200 : 10 : 1, v/v) to give 9a (29.7 mg, 54%) and 9b (4.1 mg, 8%) in
the order of elution. 9a: mp 151—153 °C (colorless needles, recrystallized
from MeOH–EtOAc). IR (KBr): 3290, 1682 (br), 1558, 1473 cm21. 1H-
NMR (DMSO-d6, 90 °C) d : 2.76 (2H, t, J57.1 Hz), 3.30 (2H, q, J57.1 Hz),
3.54 (3H, s), 6.80 (1H, dd, J52.3, 8.8 Hz), 6.80 (1H, br s), 6.93 (1H, d,
J52.3 Hz), 7.48 (1H, br s), 7.93 (1H, br s), 8.99 (1H, br s), 9.18 (1H, br s).
Anal. Calcd for C13H14N2O4: C, 59.53; H, 5.38; N, 10.68. Found: C, 59.60;
H, 5.33; N, 10.76. 9b: Colorless viscous oil. IR (film): 1686, 1525, 1262,
796 cm21. 1H-NMR (DMSO-d6) d : 2.72 (2H, t, J57.7 Hz), 3.21 (2H, dt,
J57.7, 5.6 Hz), 3.53 (3H, s), 6.58 (1H, dd, J58.6, 2.4 Hz), 6.81 (1H, d, J5
2.0 Hz), 7.02 (1H, d, J52.4 Hz), 7.12 (1H, d, J58.6 Hz), 7.18 (1H, br t,
J55.6 Hz), 8.60 (1H, s), 10.46 (1H, br s). HR-MS m/z: Calcd for
C12H14N2O3: 234.1004. Found: 234.1019.
Compound 9a from 10 A solution of 10 (50.5 mg, 0.20 mmol) in 85%
HCOOH (5.0 ml) was stirred at 80 °C for 20 min. Evaporation of the solvent
under reduced pressure afforded an oil, which was column-chromatographed
on SiO2 with CHCl3–MeOH–28% aq. NH3 (100 : 1 : 0.1, v/v) to give 9a
(36.8 mg, 69%).
Compound 9b and 5-Formyloxy-N-methoxycarbonyltryptamine (9c)
from 8d A solution of 8d (49.4 mg, 0.21 mmol) in 85% HCOOH (5.0 ml)
was stirred at room temperature for 20 min. Evaporation of the solvent under
reduced pressure afforded an oil, which was column-chromatographed on
SiO2 with CHCl3–MeOH–28% aq. NH3 (100 : 1 : 0.1, v/v) to give unreacted
8d (3.5 mg, 7%), 9c (22.1 mg, 40%), and 9b (11.7 mg, 24%) in the order of
elution. 9c: Colorless viscous oil. IR (film): 3400, 1703 (br), 1525, 1170,
780 cm21. 1H-NMR (DMSO-d6) d : 2.80 (2H, t, J57.5 Hz), 3.24 (2H, q,
J57.5 Hz), 3.52 (3H, s), 6.89 (1H, dd, J58.8, 2.5 Hz), 7.18 (1H, br t,
J58.8 Hz), 7.23 (1H, br d, J52.5 Hz), 7.31 (1H, br d, J52.5 Hz), 7.37 (1H,
d, J58.8 Hz), 8.54 (1H, s), 10,96 (1H, br s). HR-MS m/z: Calcd for
C13H14N2O4: 262.0954. Found: 262.0945.
Compound 9b and 9c from 10 A solution of 10 (49.5 mg, 0.20 mmol)
in 85% HCOOH (5.0 ml) was stirred at room temperature for 15 min. Evap-
oration of the solvent under reduced pressure afforded an oil, which was col-
umn-chromatographed on SiO2 with CHCl3–MeOH–28% aq. NH3 (100 : 1 :
0.1, v/v) to give 9c (19.8 mg, 38%) and 9b (11.5 mg, 25%) in the order of
elution.
Compound 9b from 9c 6% HCl (0.1 ml) was added to a solution of 9c
(19.1 mg, 0.07 mmol) in MeOH (3.0 ml) at 0 °C and the mixture was stirred
at room temperature for 20 min. To the reaction mixture was added H2O
under ice cooling and the whole was extracted with CHCl3–MeOH (95 : 5,
v/v). The extract was washed with brine, dried over Na2SO4, and evaporated
under reduced pressure to leave an oil, which was column-chromatographed
on SiO2 with CHCl3–MeOH–28% aq. NH3 (100 : 1 : 0.1, v/v) to give 9b
(10.2 mg, 60%).
Compound 9a from 9b A solution of 9b (71.8 mg, 0.37 mmol) in 85%
HCOOH (7.0 ml) was stirred at room temperature for 48 h. After evapora-
tion of the solvent under reduced pressure, brine was added to the residue.
The whole was extracted with CHCl3–MeOH (95 : 5, v/v). The extract was
washed with brine, dried over Na2SO4, and evaporated under reduced pres-
sure to leave an oil, which was column-chromatographed on SiO2 with
CHCl3–MeOH–28% aq. NH3 (200 : 10 : 1, v/v) to give 9a (55.5 mg, 69%)
and unreacted 9b (7.2 mg, 10%) in the order of elution.
Compound 9b from 9a 8% NaOH (0.4 ml) was added to a solution of
9a (41.2 mg, 0.15 mmol) in MeOH (3.6 ml) and the mixture was heated at
60 °C for 10 min. After cooling, the reaction mixture was made acidic (pH 3)
by adding 6% HCl. The whole was extracted with CHCl3–MeOH (95 : 5,
v/v). The extract was washed with brine, dried over Na2SO4, and evaporated
under reduced pressure to leave an oil, which was column-chromatographed
on SiO2 with CHCl3–MeOH–28% aq. NH3 (200 : 10 : 1, v/v) to give unre-
acted 9a (3.3 mg, 8%) and 9b (28.0 mg, 76%) in the order of elution.
Serotonin (1a) from 9b 40% aq. NaOH (1.0 ml) was added to a solu-
tion of 9b (51.5 mg, 0.22 mmol) in MeOH (3.0 ml) and the mixture was
heated at reflux for 4 h with stirring. After cooling, the reaction mixture was
made neutral (pH 7.0) by adding 6% HCl under ice cooling. The solvent was
evaporated under reduced pressure to leave a brown oil, which was column-
chromatographed on SiO2 with CHCl3–MeOH–28% aq. NH3 (100 : 10 : 1,
v/v) to give unreacted 9b (8.9 mg, 17%) and 1a (28.2 mg, 73%). Synthetic
product (1a) and its hydrochloride (1a ·HCl) were identical with the com-
mercially available samples, respectively.
Compound 9b from 1a Methyl chloroformate (0.13 ml, 1.70 mmol)
was added to a solution of serotonin hydrochloride (1a ·HCl, 300.7 mg,
1.41 mmol) in DMF (15.0 ml) and pyridine (1.5 ml) at 0 °C with stirring.
Stirring was continued at room temperature for an additional 1.5 h and H2O
was added. The whole was extracted with CHCl3 and the extract was washed
with brine, dried over Na2SO4, and evaporated under reduced pressure to
leave an oil, which was column-chromatographed on SiO2 with CHCl3–
MeOH (97 : 3, v/v) to give 9b (310 mg, 94%).
1-Methoxy-N-methoxycarbonyltryptamine (10) from 8d An excess
amount of ethereal CH2N2 was added to a solution of 8d (39.1 mg,
0.17 mmol) in MeOH (2.0 ml) and the mixture was stirred at room tempera-
ture for 1 h. After evaporation of the solvent, the residue was column-chro-
matographed on SiO2 with CH2Cl2–MeOH (99 : 1, v/v) to give 10 (34.3 mg,
83%). 10: Colorless viscous oil. IR (film): 1705 (br), 1525 cm21. 1H-NMR
(CDCl3) d : 2.93 (2H, t, J56.6 Hz), 3.49 (2H, q, J56.6 Hz), 3.66 (3H, s),
4.06 (3H, s), 4.76 (1H, br s), 7.10 (1H, s), 7.12 (1H, t, J58.0 Hz), 7.25 (1H,
t, J58.0 Hz), 7.42 (1H, d, J58.0 Hz), 7.57 (1H, d, J58.0 Hz). HR-MS m/z:
Calcd for C13H16N2O3: 248.1160. Found: 248.1163.
5-Methoxy-N,N-dimethyltryptamine (2e), 1c, and 6e from 8e c-
H2SO4 (5.0 ml) was added to a solution of 8e (421.2 mg, 2.06 mmol) in
MeOH (45.0 ml) and the mixture was refluxed for 29 h with stirring. After
cooling, the reaction mixture was made basic (pH 10) by adding 30% NaOH
and the whole was extracted with CHCl3–MeOH (95 : 5, v/v). The extract
was dried over Na2SO4, and evaporated under reduced pressure to leave an
oil, which was column-chromatographed on SiO2 repeatedly with CHCl3–
MeOH–28% aq. NH3 (46 : 5 : 0.5, v/v) and acetone–hexane–28% aq. NH3
(20 : 10 : 0.3, v/v) to give 6e (44.2 mg, 11%), 2e (256.4 mg, 57%), and 1c
(27.3 mg, 7%) in the order of elution. 2e: mp 68—70 °C (colorless prisms,
recrystallized from Et2O–hexane). IR (KBr): 1625, 1589, 1477, 1463, 1438,
1216 cm21. 1H-NMR (CDCl3) d : 2.35 (6H, s), 2.61—2.66 (2H, m), 2.88—
2.94 (2H, m), 3.86 (3H, s), 6.85 (1H, dd, J58.8, 2.4 Hz), 6.99 (1H, d,
J52.2 Hz, collapsed to s on addition of D2O), 7.05 (1H, d, J52.4 Hz), 7.23
(1H, dd, J58.8, 0.5 Hz), 7.97 (1H, br s). MS m/z: 218 (M1). Anal. Calcd for
C13H8N2O: C, 71.52; H, 8.31; N, 12.83. Found: C, 71.49; H, 8.55; N, 12.76.
5-Methoxy-N-methoxycarbonyl-N-methyltryptamine (2f) from 8f A
solution of 8f (125.0 mg, 0.50 mmol) in 5% H2SO4 in MeOH (50 ml) was re-
fluxed for 24 h with stirring. After cooling, the reaction mixture was made
slightly alkaline (pH 7—8) by adding 30% aq. NaOH and the whole was ex-
tracted with CHCl3. The extract was washed with brine, dried over Na2SO4,
and evaporated under reduced pressure to leave an oil, which was column-
chromatographed on SiO2 with CHCl3 to give 6f (11.3 mg, 11%), 2f
(63.3 mg, 48%), and unreacted 8f (19.4 mg, 16%) in the order of elution. 2f:
mp 112—113 °C (colorless prisms, recrystallized from MeOH). IR (KBr):
3300, 1668, 1485, 1446 cm21. 1H-NMR (DMSO-d6, 90 °C) d : 2.82 (3H, s),
2.86 (2H, m, A2 part of A2B2), 3.47 (2H, m, B2 part of A2B2), 3.56 (3H, s),
3.77 (3H, s), 6.72 (1H, dd, J58.8, 2.4 Hz), 7.01 (1H, d, J52.4 Hz), 7.04 (1H,
d, J52.4 Hz), 7.21 (1H, d, J58.8 Hz), 10.36 (1H, br s, disappeared on addi-
tion of D2O). MS m/z: 262 (M
1). Anal. Calcd for C14H18N2O3: C, 64.10; H,
6.92; N, 10.68. Found: C, 64.02; H, 6.89; N, 10.63.
5-Methoxy-N-methyltryptamine (2a) from 2f 40% aq. NaOH (3.6 ml)
was added to a solution of 2f (40.1 mg, 0.15 mmol) in MeOH (6.0 ml) and
the mixture was refluxed for 16 h with stirring. After cooling, H2O was
added to the reaction mixture and the whole was extracted with CHCl3. The
extract was washed with brine, dried over Na2SO4, and evaporated under re-
duced pressure to leave an oil, which was column-chromatographed on SiO2
with CHCl3–MeOH–28% aq. NH3 (46 : 5 : 0.5, v/v) to give 2a (29.0 mg,
93%). 2a: mp 108—109 °C (colorless prisms, recrystallized from EtOAc,
lit.,5) mp not reported). IR (KBr): 3320, 1584, 1465, 1435, 1211 cm21. 1H-
NMR (CDCl3) d : 1.69 (1H, br s, disappeared on addition of D2O), 2.45 (3H,
s), 2.89—2.97 (4H, m, A2B2), 3.87 (3H, s), 6.86 (1H, dd, J58.8, 2.4 Hz),
7.02 (1H, d, J52.1 Hz, collapsed to s on addition of D2O), 7.06 (1H, d,
J52.4 Hz), 7.25 (1H, d, J58.8 Hz), 7.98 (1H, br s, disappeared on addition
of D2O). MS m/z: 204 (M
1). Anal. Calcd for C12H16N2O: C, 70.56; H, 7.90;
N, 13.72. Found: C, 70.57; H, 7.89; N, 13.73.
1-Acetyl-5-methoxy-N,N-dimethyltryptamine (11a) from 2e A solu-
tion of 2e (50.0 mg, 0.23 mmol) in DMF (2.0 ml) was added to 60% NaH
(26.4 mg, 0.66 mmol, washed with dry benzene) at 0 °C with stirring. After
additional stirring for 15 min at room temperature, a solution of AcCl
(68.8 mg, 0.88 mmol) in DMF (1.0 ml) was added to the resultant solution
and the mixture was stirred at room temperature for 4 h. After the reaction
mixture was made basic (pH 9—10) by adding 8% aq. NaOH, the whole
was extracted with CHCl3–MeOH (95 : 5, v/v). The extract was washed with
brine, dried over Na2SO4, and evaporated under reduced pressure to leave an
oil, which was column-chromatographed on SiO2 with CHCl3–MeOH–28%
aq. NH3 (46 : 5 : 0.5, v/v) to give 11a (30.0 mg, 50%) and unreacted 2e
(13.5 mg, 27%) in the order of elution. 11a: Colorless viscous oil. IR (film):
1690, 1598, 1476 cm21. 1H-NMR (DMSO-d6) d : 2.23 (6H, s), 2.56 (2H, t,
J57.6 Hz), 2.57 (3H, s), 2.78 (2H, t, J57.6 Hz), 3.81 (3H, s), 6.91 (1H, dd,
J59, 2.4 Hz), 7.08 (1H, d, J52.4 Hz), 7.60 (1H, s), 8.18 (1H, d, J59 Hz).
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HR-MS m/z: Calcd for C15H20N2O2: 260.1525. Found: 260.1518.
1-Formyl-5-methoxy-N,N-dimethyltryptamine (11b) from 2e A solu-
tion of 2e (40.4 mg, 0.18 mmol) in 85% HCOOH (4.0 ml) was heated at
80 °C for 86 h with stirring. After evaporation of the solvent under reduced
pressure, the residue was subjected to p-TLC on SiO2 with CHCl3–MeOH–
28% aq. NH3 (46 : 5 : 0.5, v/v). Under UV light, two bands were detected.
Extraction from the upper band with CHCl3–MeOH–28% aq. NH3 (46 : 5 :
0.5, v/v) afforded 11b (22.5 mg, 50%). Extraction from the lower band with
the same solvent as above afforded unreacted 2e (13.0 mg, 32%). 11b: Col-
orless viscous oil. IR (film): 1708, 1602 cm21. 1H-NMR (DMSO-d6, 60 °C)
d : 2.37 (6H, s), 2.76 (2H, t, J57.5 Hz), 2.86 (2H, t, J57.5 Hz), 3.83 (3H, s),
6.96 (1H, dd, J58, 2.7 Hz), 7.15 (1H, d, J52.7 Hz), 7.60 (1H, s), 8.06 (1H,
br s), 9.20 (1H, br s). HR-MS m/z: Calcd for C14H18N2O2: 246.1367. Found:
246.1368.
N-Methylserotonin (1b) from 9b LiAlH4 (59.9 mg, 1.58 mmol) was
added to a solution of 9b (31.2 mg, 0.13 mmol) in anhydrous Et2O–THF
(1 : 1, v/v, 4.0 ml) and the mixture was refluxed for 26 h with stirring. After
cooling, MeOH was added to the reaction mixture to destroy excess LiAlH4.
After evaporation of the solvent under reduced pressure, the residual oil was
column-chromatographed on SiO2 with CHCl3–MeOH–28% aq. NH3 (5 : 1 :
1, v/v) to give 1b (16.4 mg, 65%). 1b: Colorless viscous oil.3) IR (film):
3380, 3280, 1618, 1578, 1460 cm21. 1H-NMR (CD3OD) d : 2.38 (3H, s),
2.82—2.90 (4H, m, A2B2), 6.66 (1H, dd, J58.5, 2.4 Hz), 6.92 (1H, dd,
J52.4, 0.5 Hz), 7.00 (1H, s), 7.15 (1H, dd, J58.5, 0.5 Hz). HR-MS m/z:
Calcd for C11H14N2O: 190.1106. Found: 190.1106.
5-Hydroxy-N,N-dimethyltryptamine (1c, Bufotenine) from 8e c-
H2SO4 (1.0 ml) was added to a solution of 8e (31.2 mg, 0.15 mmol) in H2O
(19.0 ml) and the mixture was refluxed for 6 h with stirring. After cooling,
the reaction mixture was made neutral by adding sat. aq. NaHCO3 and the
whole was extracted with CHCl3–MeOH (95 : 5, v/v). The extract was dried
over Na2SO4, and evaporated under reduced pressure to leave an oil, which
was column-chromatographed on SiO2 with CHCl3–MeOH–28% aq. NH3
(46 : 5 : 0.5, v/v) to give 6e (4.5 mg, 16%) and 1c (14.7 mg, 47%) in the order
of elution. 1c: mp 146—147 °C (colorless prisms, recrystallized from
EtOAc, lit.,3) mp 146—147 °C). IR spectrum was identical with that of the
reported chart.3) 1H-NMR (CD3OD) d : 2.41 (6H, s), 2.73 (2H, t, J58.1 Hz),
2.90 (2H, t, J58.1 Hz), 6.66 (1H, dd, J58.6, 2.4 Hz), 6.90 (1H, dd, J52.4,
0.5 Hz), 7.00 (1H, s), 7.15 (1H, dd, J58.6, 0.5 Hz). MS m/z: 204 (M1). Anal.
Calcd for C12H16N2O: C, 70.56; H, 7.90; N, 13.72. Found: C, 70.48; H, 8.17;
N, 13.58. Iodomethylate: mp 218—219 °C (colorless prisms, recrystallized
from MeOH, lit.,3) mp 214—215 °C). IR (KBr): 1620, 1584, 1475 cm21. 1H-
NMR (CD3OD) d : 3.19—3.26 (2H, m), 3.24 (9H, s), 3.57—3.62 (2H, m),
6.71 (1H, dd, J58.5, 2.4 Hz), 6.94 (1H, dd, J52.4, 0.5 Hz), 7.15 (1H, s),
7.19 (1H, dd, J58.5, 0.5 Hz). Anal. Calcd for C13H19N2OI: C, 45.10; H,
5.53; N, 8.09. Found: C, 44.98; H, 5.66; N, 7.80. Monopicrate: mp 185—
186 °C (orange prisms, recrystallized from MeOH, lit.,3) mp 179—180 °C).
IR (KBr): 1626, 1609, 1561, 1333 cm21. 1H-NMR (DMSO-d6) d : 2.85 (6H,
s), 2.98 (2H, t, J58.1 Hz), 3.29 (2H, t, J58.1 Hz), 6.64 (1H, dd, J58.5,
2.4 Hz), 6.87 (1H, d, J52.4 Hz), 7.13 (1H, d, J52.4 Hz, collapsed to s on ad-
dition of D2O), 7.16 (1H, d, J58.5 Hz), 8.59 (2H, s), 8.64 (1H, s, disap-
peared on addition of D2O), 9.15 (1H, br s, disappeared on addition of D2O),
10.63 (1H, br s, disappeared on addition of D2O). Anal. Calcd for
C12H16N2O ·C6H3N3O7: C, 49.88; H, 4.42; N, 16.16. Found: C, 49.84; H,
4.38; N, 15.90.
Compound 1c from 2e 1 M solution of BBr3 in toluene (5.7 ml,
5.7 mmol) was added to a solution of 2e (245.4 mg, 1.13 mmol) in CH2Cl2
(12.0 ml) at 215 °C and the mixture was stirred at 215 °C for an additional
4 h. After addition of ice and H2O, the mixture was made basic (pH 8—9) by
adding 30% aq. NaOH. The whole was extracted with CHCl3–MeOH (9 : 1,
v/v). The extract was washed with brine, dried over Na2SO4, and evaporated
under reduced pressure to leave an oil, which was column-chromatographed
on SiO2 with CHCl3–MeOH–28% aq. NH3 (46 : 5 : 0.5, v/v) to give unre-
acted 2e (58.5 mg, 24%) and 1c (145.4 mg, 63%) in the order of elution.
5-Benzyloxy-1-formyl-N-methoxycarbonyltryptamine (12a) from 9a
A solution of benzyl bromide (217.7 mg, 1.27 mmol) in anhydrous DMF
(1.0 ml) was added to a mixture of K2CO3 (165.3 mg, 1.20 mmol) and 9a
(104.3 mg, 0.39 mmol) in anhydrous DMF (2.0 ml), and the whole was
stirred at room temperature for 2.5 h. After addition of H2O, the whole was
extracted with CHCl3–MeOH (95 : 5, v/v). The extract was washed with
brine, dried over Na2SO4, and evaporated under reduced pressure to leave an
oil, which was column-chromatographed on SiO2 with EtOAc–hexane (1 : 4,
v/v) to give 12a (132.1 mg, 94%). 12a: pale yellow oil. IR (film): 3300,
1700, 1600, 1478 cm21. 1H-NMR (DMSO-d6, 90 °C) d : 2.81 (2H, t,
J57.2 Hz), 3.32 (2H, q, J57.2 Hz), 3.54 (3H, s), 5.16 (2H, s), 6.84 (1H,
br s), 7.03 (1H, dd, J52.4, 8.8 Hz), 7.24 (1H, d, J52.4 Hz), 7.31 (1H, t,
J57.7 Hz), 7.38 (2H, t, J57.7 Hz), 7.47 (2H, d, J57.7 Hz), 7.55 (1H, s),
8.04 (1H, br d, J58.8 Hz), 9.24 (1H, br s). HR-MS m/z: Calcd for
C20H20N2O4: 352.1423. Found: 352.1421.
5-Benzyloxytryptamine (12b) from 12a 40% aq. NaOH (2.0 ml) was
added to a solution of 12a (174.9 mg, 0.50 mmol) in MeOH (6.0 ml) and the
mixture was refluxed for 4 h with stirring. After addition of H2O, the whole
was extracted with CHCl3–MeOH (95 : 5, v/v). The extract was washed with
brine, dried over Na2SO4, and evaporated under reduced pressure to leave an
oil, which was column-chromatographed on SiO2 with CHCl3–MeOH–28%
aq. NH3 (46 : 2 : 0.2, v/v) to give 12b (126.5 mg, 96%). 12b: mp 97.5—
99.5 °C (colorless powder, recrystallized from CHCl3–hexane). IR (KBr):
1585, 1490, 1465, 1205, 1010 cm21. 1H-NMR (CDCl3) d : 1.51 (2H, br s,
disappeared on addition of D2O), 2.86 (2H, t, J56.6 Hz), 3.01 (2H, t, J5
6.6 Hz), 5.11 (2H, s), 6.94 (1H, dd, J52.5, 8.8 Hz), 7.02 (1H, d, J52.5 Hz),
7.14 (1H, d, J52.5 Hz), 7.25 (1H, d, J58.8 Hz), 7.31 (1H, br t, J57.7 Hz),
7.38 (2H, br t, J57.7 Hz), 7.48 (2H, br d, J57.7 Hz), 7.94 (1H, br s, disap-
peared on addition of D2O). MS m/z: 266 (M
1). Anal. Calcd for
C17H18N2O ·1/8H2O: C, 76.02; H, 6.85; N, 10.43. Found: C, 76.10; H, 6.81;
N, 10.49.
N-[2-(5-Benzyloxyindol-3-yl)ethyl]succinamic Acid (3b) from 12b
Succinic anhydride (22.6 mg, 0.22 mmol) was added to a solution of 12b
(49.0 mg, 0.18 mmol) in anhydrous THF (4.0 ml) and the mixture was stirred
at room temperature for 20 min. The solvent was evaporated under reduced
pressure to leave an oil, which was column-chromatographed on SiO2 with
CHCl3–MeOH–AcOH (46 : 5 : 0.5, v/v) to give 3b (64.6 mg, 96%). 3b: mp
145—147 °C (colorless plates, recrystallized from MeOH–CHCl3). IR
(KBr): 3400, 1710, 1610, 1545, 1195 cm21. 1H-NMR (CDCl3) d : 2.41—
2.44 (2H, m), 2.63—2.66 (2H, m), 2.95 (2H, t, J56.6 Hz), 3.61 (2H, q,
J56.6 Hz), 5.11 (2H, s), 5.75 (1H, br t, J56.6 Hz), 6.96 (1H, dd, J58.8,
2.2 Hz), 7.02 (1H, d, J52.2 Hz), 7.11 (1H, d, J52.2 Hz), 7.28 (1H, t,
J58.8 Hz), 7.32 (1H, t, J57.7 Hz), 7.39 (2H, br t, J57.7 Hz), 7.48 (2H, d,
J57.7 Hz), 8.02 (1H, br s, disappeared on addition of D2O). Anal. Calcd for
C21H22N2O4: C, 68.83; H, 6.05; N, 7.65. Found: C, 68.73; H, 6.02; N, 7.57.
Methyl N-[2-(5-Benzyloxyindol-3-yl)ethyl]succinamate (3d) and N-[2-
(5-Benzyloxyindol-3-yl)ethyl]succinimide (13a) from 3b An excess
amount of ethereal CH2N2 was added to a solution of 3b (166.0 mg,
0.45 mmol) in MeOH (5.0 ml) at room temperature and stirring was contin-
ued for 10 min. After evaporation of the solvent under reduced pressure, the
residual oil was column-chromatographed with CHCl3–MeOH (99 : 1, v/v)
to give 13a (47.5 mg, 30%) and 3d (98.7 mg, 57%) in the order of elution.
3d: mp 108—110 °C (colorless needles, recrystallized from CHCl3–hexane).
IR (KBr): 3390, 1725, 1658 cm21. 1H-NMR (CDCl3) d : 2.40 (2H, t,
J56.8 Hz), 2.65 (2H, t, J56.8 Hz), 2.92 (2H, t, J56.6 Hz), 3.58 (2H, q,
J56.6 Hz), 3.65 (3H, s), 5.11 (2H, s), 5.67 (1H, br t, J56.6 Hz), 6.95 (1H,
dd, J58.6, 2.4 Hz), 7.04 (1H, d, J52.2 Hz), 7.13 (1H, d, J52.4 Hz), 7.27
(1H, d, J58.6 Hz), 7.32 (1H, t, J57.4 Hz), 7.39 (2H, t, J57.4 Hz), 7.48 (2H,
d, J57.4 Hz), 7.98 (1H, br s). Anal. Calcd for C22H24N2O4: C, 69.45; H,
6.36; N, 7.36. Found: C, 69.43; H, 6.34; N, 7.31. 13a: mp 172—174 °C (col-
orless powder, recrystallized from CHCl3–hexane). IR (KBr): 3380, 1767,
1690 cm21. 1H-NMR (CDCl3) d : 2.62 (4H, s), 3.01 (2H, t, J57.6 Hz), 3.81
(2H, t, J57.6 Hz), 5.12 (2H, s), 6.93 (1H, dd, J58.8, 2.4 Hz), 7.06 (1H, d,
J52.4 Hz), 7.23 (1H, s), 7.24 (1H, d, J58.8 Hz), 7.31 (1H, br t, J57.6 Hz),
7.38 (2H, t, J57.6 Hz), 7.51 (2H, d, J57.6 Hz), 7.90 (1H, br s). Anal. Calcd
for C21H20N2O3: C, 72.39; H, 5.79; N, 8.04. Found: C, 72.15; H, 5.72; N,
7.98.
Compound 3d from 3b An excess amount of ethereal CH2N2 was
added to a solution of 3b (99.6 mg, 0.27 mmol) in MeOH (3.0 ml) at 0 °C
and stirring was continued for 10 min at 0 °C. After evaporation of the sol-
vent under reduced pressure, the residual oil was column-chromatographed
with CHCl3–MeOH (99 : 1, v/v) to give 3d (101.0 mg, 97%).
Bufobutanoic Acid (3a) from 3b A solution of 3b (54.2 mg,
0.15 mmol) in MeOH (3.0 ml) was hydrogenated in the presence of 10%
Pd/C (53.4 mg) at room temperature and 1 atm for 1 h. Catalyst was filtered
off and the filtrate was evaporated under reduced pressure to leave an oil,
which was column-chromatographed on SiO2 with CHCl3–MeOH–AcOH
(46 : 5 : 0.5, v/v) to give 3a (40.4 mg, 99%). 3a: Pale brown oil. IR (film):
3390, 1710, 1620, 1580, 1540, 1485, 1460, 1365, 1185, 938, 800 cm21. 1H-
NMR (DMSO-d6) d : 2.32 (2H, t, J57.2 Hz), 2.43 (2H, t, J57.2 Hz), 2.70
(2H, t, J57.6 Hz), 3.28 (2H, q, J57.6 Hz), 6.58 (1H, dd, J58.6, 2.2 Hz),
6.81 (1H, d, J52.2 Hz), 7.02 (1H, d, J52.2 Hz), 7.11 (1H, d, J58.6 Hz),
7.94 (1H, t, J57.6 Hz), 8.60 (1H, br s, disappeared on addition of D2O),
10.45 (1H, s). HR-MS m/z: Calcd for C14H16N2O4: 276.1110. Found:
276.1109. Spectral data are identical with the reported values.8)
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N-[2-(Indol-3-yl)ethyl]succinimide (13b) and Methyl N-[2-(Indol-3-
yl)ethyl]succinamate (14) from 6c Succinic anhydride (750.8 mg,
7.50 mmol) was added to a solution of 6c (1.00 g, 6.25 mmol) in anhydrous
THF (50.0 ml) and the mixture was stirred at room temperature for 20 min.
After evaporation of the solvent, the residue was dissolved in MeOH
(10.0 ml) and excess ethereal CH2N2 was added to the resultant solution.
After stirring at room temperature for 5 min, the solvent was evaporated
under reduced pressure to leave an oil, which was column-chromatographed
on SiO2 with CHCl3–MeOH (99 : 1, v/v) to give 13b (50.3 mg, 3%) and 14
(1.53 g, 89%) in the order of elution. 13b: mp 178—180 °C (colorless
prisms, recrystallized from CHCl3–hexane). IR (KBr): 1770, 1690 cm
21. 1H-
NMR (CDCl3) d : 2.61 (4H, s), 3.06 (2H, t, J57.6 Hz), 3.83 (2H, t,
J57.6 Hz), 7.09 (1H, d, J52.4 Hz), 7.13 (1H, ddd, J58.0, 7.0, 1.0 Hz), 7.19
(1H, ddd, J58.0, 7.0, 1.0 Hz), 7.35 (1H, d, J58.0 Hz), 7.67 (1H, d,
J58.0 Hz), 8.02 (1H, br s). Anal. Calcd for C14H14N2O2: C, 69.40; H, 5.83;
N, 11.56. Found: C, 69.31; H, 5.79; N, 11.59. 14: mp 118—120 °C (color-
less needles, recrystallized from CHCl3). IR (KBr): 1723, 1650, 1545, 1230,
740 cm21. 1H-NMR (CDCl3) d : 2.40 (2H, t, J56.8 Hz), 2.65 (2H, t,
J56.8 Hz), 2.97 (2H, t, J56.8 Hz), 3.60 (2H, q, J56.8 Hz), 3.66 (3H, s),
5.67 (1H, br s), 7.06 (1H, d, J52.4 Hz), 7.13 (1H, ddd, J58.1, 7.1, 1.0 Hz),
7.21 (1H, ddd, J58.1, 7.1, 1.0 Hz), 7.38 (1H, dt, J58.1, 1.0 Hz), 7.61 (1H,
dd, J58.1, 1.0 Hz), 8.07 (1H, br s). MS m/z: 274 (M1). Anal. Calcd for
C15H18N2O3·1/8H2O: C, 65.14; H, 6.65; N, 10.13. Found: C, 65.07; H, 6.61;
N, 10.27.
N-[2-(5-Hydroxyindol-3-yl)ethyl]succinimide (13c) from 3c 14% aq.
K2CO3 (3.0 ml) was added to a solution of 3c (72.6 mg, 0.25 mmol) in
MeOH (3.0 ml) and the mixture was stirred at room temperature for 40 min.
AcOH was added to the reaction mixture until the pH of the whole became
5.0. Evaporation of the solvent under reduced pressure left brown solid,
which was column-chromatographed with EtOAc–hexane (1 : 2, v/v) to give
13c (16.7 mg, 26%). 13c: mp 219—221 °C (colorless needles, recrystallized
from CHCl3–MeOH). IR (KBr): 3400, 3300, 1763, 1680 cm
21. 1H-NMR
(DMSO-d6) d : 2.61 (4H, s), 2.76—2.79 (2H, m), 3.55—3.58 (2H, m), 6.59
(1H, dd, J58.6, 2.2 Hz), 6.84 (1H, d, J52.2 Hz), 7.07 (1H, d, J52.2 Hz),
7.12 (1H, d, J58.6 Hz), 8.63 (1H, s, disappeared on addition of D2O), 10.51
(1H, s). MS m/z: 258 (M1). Anal. Calcd for C14H14N2O3·1/8H2O: C, 64.54;
H, 5.51; N, 10.75. Found: C, 64.59; H, 5.35; N, 10.61.
Methyl N-[2-(2,3-Dihydroindol-3-yl)ethyl]succinamate (15) from 14
Et3SiH (0.12 ml, 0.73 mmol) was added to a solution of 14 (100.1 mg,
0.36 mmol) in TFA (5.0 ml) and the mixture was stirred at 60 °C for 4 h.
After evaporation of the solvent, the whole was made basic by adding satu-
rated NaHCO3 under ice cooling and extracted with CHCl3–MeOH (95 : 5,
v/v). The extract was washed with brine, dried over Na2SO4, and evaporated
under reduced pressure to leave an oil, which was column-chromatographed
on SiO2 with CHCl3–MeOH (97 : 3, v/v) to give 15 (99.6 mg, 99%). 15: mp
74—75 °C (colorless prisms, recrystallized from CHCl3–hexane). IR (KBr):
1724, 1645 cm21. 1H-NMR (CDCl3) d : 1.73—1.81 (1H, m), 1.95—2.02
(1H, m), 2.43 (2H, t, J56.8 Hz), 2.63—2.68 (2H, m), 3.26—3.41 (4H, m),
3.68 (3H, s), 3.70 (1H, t, J58.8 Hz), 5.82 (1H, br s), 6.65 (1H, d, J57.5 Hz),
6.73 (1H, dt, J51.0, 7.5 Hz), 7.04 (1H, br t, J57.5 Hz), 7.09 (1H, br d, J5
7.5 Hz). MS m/z: 276 (M1). Anal. Calcd for C15H20N2O3: C, 65.19; H, 7.30;
N, 10.14. Found: C, 65.22; H, 7.37; N, 10.04.
Methyl N-[2-(1-Hydroxyindol-3-yl)ethyl]succinamate (16) from 15 A
solution of Na2WO4·2H2O (24.1 mg, 0.07 mmol) in H2O (1.0 ml) was added
to a solution of 15 (100.6 mg, 0.36 mmol) in MeOH (10.0 ml) and then 30%
H2O2 (0.37 ml, 3.64 mmol) was added to the reaction mixture at 0 °C. After
stirring at room temperature for 1 h, H2O was added to the reaction mixture
and the whole was extracted with CHCl3. The extract was washed with
brine, dried over Na2SO4, and evaporated under reduced pressure to leave an
oil, which was column-chromatographed repeatedly on SiO2 with
EtOAc–hexane (1 : 1, v/v) and CHCl3–MeOH (99 : 1, v/v) to give 16
(59.4 mg, 56%) and unreacted 15 (6.6 mg, 7%) in the order of elution. 16:
mp 151.5—153.5 °C (colorless needles, recrystallized from EtOAc–hexane).
IR (KBr): 3370, 1715, 1640, 1555, 740 cm21. 1H-NMR (CD3OD) d : 2.45
(2H, t, J56.8 Hz), 2.58 (2H, t, J56.8 Hz), 2.90 (2H, t, J57.2 Hz), 3.45 (2H,
t, J57.2 Hz), 3.65 (3H, s), 6.99 (1H, t, J58.0 Hz), 7.11 (1H, s), 7.13 (1H, t,
J58.0 Hz), 7.34 (1H, d, J58.0 Hz), 7.53 (1H, d, J58.0 Hz). MS m/z: 290
(M1). Anal. Calcd for C15H18N2O4·1/8H2O: C, 61.58; H, 6.29; N, 9.58.
Found: C, 61.57; H, 6.18; N, 9.41.
Methyl N-[2-(5-Hydroxyindol-3-yl)ethyl]succinamate (3c) and Methyl
N-[2-(1-Formyl-5-hydroxyindol-3-yl)ethyl]succinamate (3e) from 16 A
solution of 16 (134.6 mg, 0.46 mmol) in 85% HCOOH (40.0 ml) was stirred
at 50 °C for 50 min. The solvent was evaporated under reduced pressure to
leave an oil, which was column-chromatographed repeatedly on SiO2 with
EtOAc–hexane (1 : 1, v/v) and CHCl3–MeOH (99 : 1, v/v) to give 3e
(30.6 mg, 21%) and 3c (50.6 mg, 38%) in the order of elution. 3c: Colorless
oil. IR (film): 3320, 1730, 1645 cm21. 1H-NMR (CDCl3) d : 2.42 (2H, t, J5
6.3 Hz), 2.69 (2H, t, J56.3 Hz), 2.91 (2H, t, J56.3 Hz), 3.51 (2H, q, J5
6.3 Hz), 3.73 (3H, s), 5.66 (1H, br t, J56.3 Hz), 6.07 (1H, br s, disappeared
on addition of D2O), 6.82 (1H, dd, J58.8, 2.5 Hz), 7.00 (1H, d, J52.5 Hz),
7.06 (1H, d, J52.5 Hz), 7.22 (1H, d, J58.8 Hz), 7.91 (1H, br s, disappeared
on addition of D2O). HR-MS m/z: Calcd for C15H18N2O4: 290.1267. Found:
290.1264. 3e: mp 178—180 °C (colorless needles, recrystallized from
MeOH–CHCl3). IR (KBr): 3350, 1727, 1697, 1648 cm
21. 1H-NMR (DMSO-
d6, 90 °C) d : 2.36 (2H, t, J57.5 Hz), 2.50 (2H, t, J57.5 Hz), 2.74 (2H, t,
J57.5 Hz), 3.36 (2H, q, J57.5 Hz), 3.58 (3H, s), 6.80 (1H, dd, J58.7,
2.2 Hz), 6.93 (1H, d, J52.2 Hz), 7.47 (1H, s), 7.70 (1H, br s), 7.93 (1H, br s),
9.00 (1H, br s), 9.18 (1H, br s). MS m/z: 318 (M1). Anal. Calcd for
C16H18N2O5: C, 60.37; H, 5.70; N, 8.80. Found: C, 60.29; H, 5.63; N, 8.73.
Bufobutanoic Acid (3a) from 3c 14% aq. K2CO3 (2.0 ml) was added to
a solution of 3c (18.1 mg, 0.062 mmol) in MeOH (2.0 ml) at 0 °C and the
mixture was stirred at 50 °C for 1 h. The whole was made acidic by adding
6% HCl under ice cooling and evaporated under reduced pressure to leave
an oil, which was column-chromatographed on SiO2 with CHCl3–MeOH–
AcOH (46 : 5 : 0.5, v/v) to give unreacted 3c (2.5 mg, 14%) and 3a (12.1 mg,
70%) in the order of elution.
Compound 3a from 1a Succinic anhydride (63.5 mg, 0.64 mmol) was
added to a solution of serotonin hydrochloride (1a ·HCl, 103.9 mg,
0.49 mmol) in DMF (5.0 ml) and pyridine (0.5 ml) at room temperature and
stirring was continued for 10 h. After evaporation of solvent under reduced
pressure, the residual oil was column-chromatographed on SiO2 with
CHCl3–MeOH–AcOH (46 : 5 : 0.5, v/v) to give 3a (113.0 mg, 84%) and un-
reacted 1a (12.7 mg, 15%) in the order of elution.
N-Indol-3-ylmethyl-N-methyltryptamine (18) from 6a A solution of
n-Bu3P (23.0 mg, 0.11 mmol) in MeCN (3.0 ml) was added to a mixture of
6a (36.4 mg, 0.21 mmol) and gramine (17, 44.3 mg, 0.25 mmol) and the re-
sultant solution was refluxed for 15 h under Ar atmosphere with stirring.
After evaporation of the solvent under reduced pressure, the residual oil was
column-chromatographed on SiO2 with CHCl3–MeOH–28% aq. NH3 (46 :
5 : 0.5, v/v) to give 18 (46.3 mg, 73%), 17 (6.8 mg), and unreacted 6a
(9.5 mg, 26%) in the order of elution. 18: mp 119—121 °C (colorless
prisms, recrystallized from acetone–hexane). IR (KBr): 3400, 1619,
1450 cm21. 1H-NMR (CDCl3) d : 2.38 (3H, s), 2.81 (2H, m, A2 part of
A2B2), 3.03 (2H, m, B2 part of A2B2), 3.81 (2H, s), 6.97 (1H, d, J52.5 Hz),
7.06—7.13 (3H, m), 7.15—7.21 (2H, m), 7.32 (1H, d, J58.3 Hz), 7.34 (1H,
d, J58.1 Hz), 7.54 (1H, d, J58.1 Hz), 7.72 (1H, d, J57.8 Hz), 7.95 (1H, br s,
disappeared on addition of D2O), 8.09 (1H, br s, disappeared on addition of
D2O). MS m/z: 303 (M
1). Anal. Calcd for C20H21N3: C, 79.17; H, 6.98; N,
13.85. Found: C, 79.11; H, 7.08; N, 13.60.
1-Ethyl- (19b) and/or 2,3-Dihydro-N-indol-3-ylmethyl-N-methyltrypt-
amine (19a) from 18: Method A: NaBH3CN (308.9 mg, 4.92 mmol) was
added to a solution of 18 (298.8 mg, 0.98 mmol) in AcOH (12.0 ml) and
TFA (4.0 ml) and the mixture was stirred for 13 h at room temperature. After
addition of H2O, the mixture was made basic (pH 10) by adding 8% aq.
NaOH and the whole was extracted with CHCl3. The extract was washed
with brine, dried over Na2SO4, and evaporated under reduced pressure to
leave an oil, which was column-chromatographed on SiO2 with
CHCl3–MeOH–28% aq. NH3 (46 : 5 : 0.5, v/v) to give 19a (213.0 mg, 71%).
19a: Colorless viscous oil. IR (film): 3390, 1606, 1485, 1457 cm21. 1H-
NMR (CD3OD) d : 1.72—1.80 (1H, m), 2.02—2.10 (1H, m), 2.29 (3H, s),
2.52 (1H, ddd, J512.2, 10.7, 5.1 Hz), 2.61 (1H, ddd, J512.2, 10.7, 5.6 Hz),
3.07 (1H, dd, J58.9, 7.1 Hz), 3.18—3.25 (1H, m), 3.51 (1H, t, J58.9 Hz),
3.76 (1H, d, J513.4 Hz), 3.80 (1H, d, J513.4 Hz), 6.64 (1H, d, J57.3 Hz),
6.65 (1H, dt, J51, 7.3 Hz), 6.96 (1H, br t, J57.3 Hz), 6.99 (1H, br d,
J57.3 Hz), 7.03 (1H, ddd, J58.1, 7.1, 1 Hz), 7.10 (1H, ddd, J58.1, 7.1,
1 Hz), 7.19 (1H, s), 7.35 (1H, dt, J58.1, 1 Hz), 7.62 (1H, dt, J58.1, 1 Hz).
HR-MS m/z: Calcd for C20H23N3: 305.1892. Found: 305.1895.
Method B: NaBH3CN (39.8 mg, 0.63 mmol) was added to a solution of
18 (25.5 mg, 0.08 mmol) in AcOH (2.0 ml) and the mixture was stirred for
7 h at room temperature After addition of H2O, the mixture was made basic
(pH 10) by adding 8% aq. NaOH and the whole was extracted with CHCl3.
The extract was washed with brine, dried over Na2SO4, and evaporated
under reduced pressure to leave an oil, which was column-chromatographed
on SiO2 with CHCl3–MeOH–28% aq. NH3 (46 : 5 : 0.5, v/v) to give 19b
(3.1 mg, 11%), 19a (7.1 mg, 28%), and unreacted 18 (15.3 mg, 60%). 19b:
Colorless viscous oil. IR (film): 3410, 1603, 1486, 1455 cm21. 1H-NMR
(CD3OD) d : 1.10 (3H, t, J57.2 Hz), 1.70—1.78 (1H, m), 2.01—2.09 (1H,
m), 2.32 (3H, s), 2.52 (1H, ddd, J512.2, 10.8, 4.9 Hz), 2.63 (1H, ddd,
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J512.2, 10.8, 5.6 Hz), 2.84 (1H, dd, J58.7, 7 Hz), 3.01 (1H, dq, J513.2,
7.2 Hz), 3.09—3.16 (1H, m), 3.10 (1H, dq, J513.2, 7.2 Hz), 3.34 (1H, t,
J58.7 Hz), 3.77 (1H, d, J513.4 Hz), 3.83 (1H, d, J513.4 Hz), 6.48 (1H, d,
J57.3 Hz), 6.59 (1H, dt, J51, 7.3 Hz), 6.95 (1H, d, J57.3 Hz), 7.00 (1H,
br t, J57.3 Hz), 7.03 (1H, ddd, J58.1, 7.1, 1 Hz), 7.10 (1H, ddd, J58.1, 7.1,
1 Hz), 7.20 (1H, s), 7.36 (1H, dt, J58.1, 1 Hz), 7.62 (1H, dt, J58.1, 1 Hz).
HR-MS m/z: Calcd for C22H27N3: 333.2205. Found: 333.2201.
1-Hydroxy-N-indol-3-ylmethyl-N-methyltryptamine (20) from 19a A
solution of Na2WO4·2H2O (54.3 mg, 0.16 mmol) in H2O (2.8 ml) was added
to a solution of 19a (213.0 mg, 0.70 mmol) in MeOH (28.0 ml). To the resul-
tant solution was added 30% H2O2 (0.72 ml, 7.05 mmol) at 0 °C with stir-
ring. After stirring at room temperature for 1 h, Me2S (0.6 ml, 8.2 mmol) was
added to the reaction mixture cautiously under ice-cooling. Stirring was con-
tinued at room temperature for 30 min and the whole was extracted with
CHCl3. The extract was washed with brine, dried over Na2SO4, and evapo-
rated under reduced pressure to leave an oil, which was column-chro-
matographed on SiO2 with CHCl3–MeOH–28% aq. NH3 (46 : 5 : 0.5, v/v) to
give 20 (113.9 mg, 51%). 20: mp 173—174 °C (decomp., colorless prisms,
recrystallized from acetone). IR (KBr): 3380, 1540, 1451 cm21. 1H-NMR
(DMSO-d6) d : 2.24 (3H, s), 2.65 (2H, t, J57.8 Hz), 2.88 (2H, t, J57.8 Hz),
3.71 (2H, s), 6.92 (1H, ddd, J57.8, 7.1, 1 Hz), 6.95 (1H, ddd, J57.8, 7.1,
1 Hz), 7.06 (1H, ddd, J58.1, 7.1, 1 Hz), 7.10 (1H, ddd, J58.1, 7.1, 1 Hz),
7.21 (1H, d, J52.1 Hz), 7.22 (1H, s), 7.30 (1H, d, J58.1 Hz), 7.34 (1H, d,
J58.2 Hz), 7.40 (1H, d, J57.8 Hz), 7.61 (1H, d, J57.8 Hz), 10.87 (1H, br s,
disappeared on addition of D2O), 10.97 (1H, br s, disappeared on addition of
D2O). MS m/z: 319 (M
1). Anal. Calcd for C20H21N3O ·1/8H2O: C, 74.68; H,
6.66; N, 13.06. Found: C, 74.65; H, 6.65; N, 12.90.
N-Indol-3-ylmethyl-5-methoxy-N-methyltryptamine (4) from 2a A
solution of n-Bu3P (22.9 mg, 0.11 mmol) in MeCN (5.0 ml) was added to a
mixture of 2a (57.3 mg, 0.28 mmol) and gramine (17, 59.6 mg, 0.34 mmol)
and the resultant solution was refluxed for 24 h under an Ar atmosphere with
stirring. After evaporation of the solvent under reduced pressure, the resid-
ual oil was column-chromatographed on SiO2 with CHCl3–MeOH–28% aq.
NH3 (46 : 5 : 0.5, v/v) to give 4 (73.0 mg, 78%), 17 (12.1 mg), and unreacted
2a (12.0 mg, 21%) in the order of elution. 4: Colorless viscous oil (lit.,7)
amorphous whitish powder). Although IR and 1H-NMR data differ slightly
from the reported values,7) we found that proton signals shift markedly de-
pending on the deuterated solvent and concentration. The data of 13C-NMR
are completely identical with the reported values.7) IR (CHCl3): 3450 (br),
2780, 1621, 1585, 1483, 1451 cm21. 1H-NMR (5% CD3OD in CDCl3) d :
2.40 (3H, s), 2.81 (2H, m, A2 part of A2B2), 3.00 (2H, m, B2 part of A2B2),
3.79 (3H, s), 3.85 (2H, s), 6.82 (1H, dd, J58.8, 2.5 Hz), 6.95 (1H, s), 6.97
(1H, d, J52.5 Hz), 7.11 (1H, ddd, J58.1, 7, 1 Hz), 7.17 (1H, s), 7.18 (1H,
ddd, J58.1, 7, 1 Hz), 7.23 (1H, d, J58.8 Hz), 7.37 (1H, dt, J58.1, 1 Hz),
7.69 (1H, dt, J58.1, 1 Hz). HR-MS m/z: Calcd for C21H23N3O: 333.1841.
Found: 333.1852.
Compound 4 from 20 A solution of 20 (29.8 mg, 0.09 mmol) in 10%
H2SO4 in MeOH (4.0 ml) was refluxed for 6 h with stirring. After cooling,
the reaction mixture was made basic (pH 10) by adding 20% aq. NaOH and
the whole was extracted with CHCl3–MeOH (9 : 1, v/v). The extract was
washed with brine, dried over Na2SO4, and evaporated under reduced pres-
sure to leave an oil, which was column-chromatographed on SiO2 with
CHCl3–MeOH–28% aq. NH3 (46 : 5 : 0.5, v/v) to give 4 (5.8 mg, 19%), 18
(2.6 mg, 9%), and unreacted 20 (15.9 mg, 53%) in the order of elution.
1-Hydroxy-2-oxindole (26) from Methyl 2-Nitrophenylacetate (25)
Zn (314.6 mg, 4.81 mg atom) was added to a solution of 25 (46.1 mg,
0.23 mmol) and NH4Cl (49.3 mg, 0.92 mmol) in MeOH (2.0 ml) and H2O
(0.5 ml) and the mixture was stirred at room temperature for 3 h. To the reac-
tion mixture, CH2Cl2–MeOH (95 : 5, v/v) was added. The precipitates were
filtered off through thin SiO2 layer and washed with CH2Cl2–MeOH (95 : 5,
v/v). The filtrate and washings were combined and evaporated under reduced
pressure to leave the residue, which was made acidic by adding 0.3% aq.
HCl and the whole was extracted with CH2Cl2–MeOH (95 : 5, v/v). The ex-
tract was washed with brine, dried over Na2SO4, and evaporated under re-
duced pressure to leave an oil, which was subjected to p-TLC on SiO2 with
CH2Cl2–MeOH (95 : 5, v/v) to give 26 (16.8 mg, 48%). 26: mp 200.5—
202.0 °C (colorless prisms, recrystallized from CH2Cl2–MeOH, lit.,
25) mp
199—201 °C). IR (KBr): 1675, 1617 cm21. 1H-NMR (10% CD3OD in
CDCl3) d : 3.35 (1H, br s), 3.43 (2H, s), 6.65—7.41 (4H, m).
Zinc Complex of 1-Hydroxy-2-oxindole (27) from 25 Zn (6.405 g,
98 mg atom) was added to a solution of 25 (1.018 g, 5.2 mmol) and NH4Cl
(1.084 g, 20.2 mmol) in MeOH (40 ml) and H2O (10 ml) and the mixture was
stirred at room temperature for 3 h. The precipitates were filtered off through
filter paper and washed with hot MeOH. The filtrate and washings were
combined and evaporated under reduced pressure to dryness. Acetone was
added to the residue, and the precipitates were removed through thin SiO2
layer. The filtrate was evaporated under reduced pressure to leave a crys-
talline solid, which was recrystallized from CH2Cl2–MeOH (95 : 5, v/v) to
give 27 (243.7 mg, 26%) as colorless prisms. 27: mp .300 °C. IR (KBr):
1630, 1605 cm21. 1H-NMR (pyridine-d5) d : 3.28 (4H, s), 6.62—7.38 (8H,
m). HR-MS m/z: Calcd for C16H12N2O4Zn: 360.0087 and 362.0057. Found:
360.0109 and 361.9963.
1-Acetoxy-2-oxindole (28) from 25 Zn (6.590 g, 100 mg atom) was
added to a solution of 25 (1.035 g, 5.4 mmol) and NH4Cl (1.137 g,
21.2 mmol) in MeOH (40 ml) and H2O (10 ml) and the mixture was stirred at
room temperature for 3 h. The precipitates were filtered off through filter
paper and washed with hot MeOH. The filtrate and washings were combined
and evaporated under reduced pressure to dryness. To the residue, pyridine
(20 ml) and Ac2O (10 ml) were added and the mixture was stirred at room
temperature for 4 h. After evaporation of the solvent under reduced pressure,
H2O was added to the residue and the whole was extracted with CH2Cl2. The
extract was washed with brine, dried over Na2SO4, and evaporated under re-
duced pressure to leave an oil, which was column-chromatographed on SiO2
with CH2Cl2–Et2O (10 : 1, v/v) to give 28 (709.9 mg, 70%). 28: mp 97—
99 °C (colorless prisms, recrystallized from Et2O–hexane). IR (KBr): 1807,
1727 cm21. 1H-NMR (CDCl3) d : 2.33 (3H, s), 3.55 (2H, s), 6.50—7.35 (4H,
m). MS m/z: 191 (M1). Anal. Calcd for C10H9NO3: C, 62.82; H, 4.75; N,
7.33. Found: C, 63.00; H, 4.72; N, 7.04.
Compound 26 from 28 A solution of 28 (104.2 mg, 0.54 mmol) in sat.
aq. Na2CO3 (10 ml) was heated at 100 °C for 30 min with stirring. After
cooling, the reaction mixture was made acidic by adding 18% aq. HCl and
the resultant precipitates (26, 16.5 mg) were collected by filtration. The fil-
trate was extracted with CH2Cl2–MeOH (95 : 5, v/v). The extract was
washed with brine, dried over Na2SO4, and evaporated under reduced pres-
sure to leave an oil, which was column-chromatographed on SiO2 with
Et2O–CH2Cl2 (3 : 2, v/v) to give further crop of 26 (59.8 mg). Total yield of
26 was 76.3 mg (94%).
1-Methoxy-2-oxindole (29) from 25 Zn (823.5 mg, 12.6 mg atom) was
added to a solution of 25 (121.0 mg, 0.62 mmol) and NH4Cl (130.4 mg,
2.43 mmol) in MeOH (5.0 ml) and H2O (1.2 ml) and the mixture was stirred
at room temperature for 3 h. The precipitates were filtered off through filter
paper and washed with hot MeOH. The filtrate and washings were combined
and evaporated under reduced pressure to dryness and the residue was dis-
solved in MeOH (5.0 ml). To the resultant solution, ethereal CH2N2 was
added until the gas evolution was not observed. After evaporation of the sol-
vent under reduced pressure, the residual oil was subjected to p-TLC on
SiO2 with CH2Cl2–MeOH (97 : 3, v/v) to give 29 (78.0 mg, 77%). 29: mp
84.5—86.0 °C (colorless prisms, recrystallized from Et2O, lit.,
25) mp 84—
86 °C). IR (KBr): 1712, 1617 cm21. 1H-NMR (CDCl3) d : 3.42 (2H, s), 3.95
(3H, s), 6.65—7.42 (4H, m). MS m/z: 163 (M1).
1-Methoxy-2-oxindole-3-spirocyclopropane (30) from 29 A solution
of 29 (103.4 mg, 0.63 mmol) in anhydrous DMF (2.5 ml) was added to 50%
NaH (62.8 mg, 1.30 mmol, washed with dry benzene) at 0 °C with stirring.
To the resultant solution was added a solution of ethylene dibromide
(144 mg, 2.5 mmol) in DMF (1.5 ml) and the mixture was stirred at room
temperature for 4 h. After addition of H2O under ice cooling, the whole was
extracted with benzene. The extract was washed with brine, dried over
Na2SO4, and evaporated under reduced pressure to leave an oil, which was
subjected to p-TLC on SiO2 with Et2O–hexane to give 30 (108.7 mg, 90%).
30: Colorless viscous oil. IR (film): 1723, 1619 cm21. 1H-NMR (CCl4) d :
1.17—1.54 (2H, m), 1.54—1.87 (2H, m), 3.92 (3H, s), 6.41—7.21 (4H, m).
HR-MS m/z: Calcd for C11H11NO2: 189.0789. Found: 189.0795.
1-Methoxy-3-(2-N,N-dimethylaminoethyl)-2-oxindole (31) and 2-(2-N-
Methoxyaminophenyl)-N,N-dimethyl-4-(N,N-dimethylamino)butylamide
(32) from 30 50% aq. Me2NH (12.0 ml, 107 mmol) was added to a solu-
tion of 30 (404.4 mg, 2.1 mmol) and Me2NH·HCl (1.614 g, 19.5 mmol) in
DMF (28 ml) and the mixture was sealed in a tube. The whole was heated at
6565 °C for 20 h with stirring. After cooling, the reaction mixture was made
basic with 0.8% NaOH and the whole was extracted with benzene. The ex-
tract was washed with brine, dried over Na2SO4, and evaporated under re-
duced pressure to leave an oil, which was column-chromatographed on SiO2
with CHCl3–MeOH–28% aq. NH3–1,2-dichloroethane (46 : 5 : 0.5 : 2.5, v/v)
to give 31 (270.3 mg, 54%) and 32 (60.0 mg, 10%) in the order of elution.
31: Colorless viscous oil. IR (film): 1727, 1616 cm21. 1H-NMR (CCl4) d :
1.69—2.50 (4H, A2B2, m), 2.06 (6H, s), 3.32 (1H, t, J55.6 Hz), 3.86 (3H,
s), 6.57—7.29 (4H, m). HR-MS m/z: Calcd for C13H18N2O2: 234.1367.
Found: 234.1375. 32: Colorless viscous oil. IR (film): 3480, 1647 cm21. 1H-
NMR (CDCl3) d : 1.67—2.57 (4H, m), 2.32 (6H, s), 2.73 (3H, s), 2.86 (3H,
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s), 3.66 (3H, s), 3.90 (1H, dd, J58.8, 5.2 Hz), 6.50—7.30 (4H, m), 6.93 (1H,
br s). HR-MS m/z: Calcd for C15H25N3O2: 279.1944. Found: 279.1937.
2,3-Dihydro-2-hydroxy-3-[2-(N,N-dimethylamino)ethyl]-1-methoxyin-
dole (33) from 31 LiAlH4 (9.6 mg, 0.25 mmol) was added to a solution of
31 (54.1 mg, 0.23 mmol) in anhydrous Et2O (9.0 ml) and the mixture was
stirred at room temperature for 2 h. After addition of MeOH at 0 °C to the
reaction mixture to destroy excess LiAlH4, 10% aq. Rochelle salt was added
and the whole was extracted with CH2Cl2–MeOH (95 : 5, v/v). The extract
was washed with brine, dried over Na2SO4, and evaporated under reduced
pressure to leave an oil, which was column-chromatographed on SiO2 with
CHCl3–MeOH–28% aq. NH3 (46 : 5 : 0.5, v/v) to give 33 (34.0 mg, 62%).
33: Colorless viscous oil. IR (film): 3340, 1612, 1596, 1475, 1463 cm21. 1H-
NMR (CCl4) d : 1.84—2.75 (5H, m), 2.25 (6H, s), 3.82 (3H, s), 4.60 and
4.92 (total 1H, each d, J58 Hz), 5.83 (1H, br s), 6.44—7.15 (4H, m). HR-
MS m/z: Calcd for C13H20N2O2: 236.1523. Found: 236.1539.
Lespedamine (5) from 31 LiAlH4 (10.1 mg, 0.25 mmol) was added to a
solution of 31 (54.0 mg, 0.23 mmol) in anhydrous Et2O (10 ml) and the mix-
ture was stirred at room temperature for 3.5 h. After addition of MeOH at
0 °C to the reaction mixture to destroy excess LiAlH4, the mixture was made
acidic by adding 6% HCl. The whole was then made basic with 8% NaOH
and extracted with CH2Cl2–MeOH (95 : 5, v/v). The extract was washed with
brine, dried over Na2SO4, and evaporated under reduced pressure to leave an
oil, which was subjected to p-TLC on SiO2 with CHCl3–MeOH–28% aq.
NH3 (46 : 5 : 0.5, v/v) to give 5 (32.4 mg, 64%). 5: Colorless viscous oil. IR
(CHCl3): 1460 cm
21 (lit.,8) 1459 cm21). 1H-NMR (CDCl3) d : 2.37 (6H, s),
2.65 (2H, t, J58 Hz), 2.93 (2H, t, J58 Hz), 4.05 (3H, s), 7.10 (1H, dt,
J50.9, 7.8 Hz), 7.10 (1H, s), 7.23 (1H, dt, J50.9, 7.8 Hz), 7.40 (1H, dd,
J57.8, 0.9 Hz), 7.57 (1H, dd, J50.9, 7.8 Hz). HR-MS m/z: Calcd for
C13H18N2O: 218.1419. Found: 218.1416. IR and 
1H-NMR spectra are identi-
cal with those of natural product reported in the literature.8) Picrate: mp
161—163 °C (lit.,8) mp 160—162 °C).
Compound 5 from 33 Three drops of 6% HCl were added to a solution
of 33 (33.7 mg, 0.14 mmol) in MeOH (5.0 ml) at room temperature with stir-
ring. After 10 min, the reaction mixture was made basic with 0.8% NaOH
and the whole was extracted with CH2Cl2–MeOH (95 : 5, v/v). The extract
was washed with brine, dried over Na2SO4, and evaporated under reduced
pressure to leave an oil, which was subjected to p-TLC on SiO2 with CHCl3–
MeOH–28% aq. NH3 (46 : 5 : 0.5, v/v) to give 5 (29.7 mg, 95%).
Compound 5 and Lespedamine N-Oxide (24a) from 7e A solution of
Na2WO4·2H2O (15.5 mg, 0.05 mmol) in H2O (0.5 ml) was added to a solu-
tion of 7e (43.9 mg, 0.23 mmol) in MeOH (5.0 ml). To the resultant solution
was added 30% H2O2 (0.24 ml, 2.3 mmol) at 0 °C with stirring. After stirring
at room temperature for 30 min, excess ethereal CH2N2 was added and stir-
ring was continued for 30 min. H2O was added to the reaction mixture and
the whole was extracted with CHCl3–MeOH (95 : 5, v/v). The extract was
washed with brine, dried over Na2SO4, and evaporated under reduced pres-
sure to leave an oil, which was column-chromatographed on SiO2 with
CHCl3–MeOH–28% aq. NH3 (46 : 5 : 0.5, v/v) to give 5 (13.1 mg, 26%) and
24a (17.0 mg, 31%) in the order of elution. 24a: Colorless viscous oil. IR
(film): 1644 (br), 1453 cm21. 1H-NMR (CDCl3) d : 3.31 (6H, s), 3.37—3.40
(2H, m), 3.57—3.60 (2H, m), 4.06 (3H, s), 7.13 (1H, ddd, J57.9, 7.5,
1.1 Hz), 7.18 (1H, s), 7.25 (1H, ddd, J57.9, 7.5, 1.1 Hz), 7.42 (1H, dt,
J57.9, 1.1 Hz), 7.59 (1H, dt, J57.9, 1.1 Hz). HR-MS m/z: Calcd for
C13H18N2O2: 234.1368. Found: 234.1370.
Compound 5 from 8e Excess ethereal CH2N2 was added to a solution
of 8e (13.1 mg, 0.06 mmol) in MeOH (5.0 ml) and stirring was continued at
room temperature for 30 min. After removal of the solvent under reduced
pressure, the residue was subjected to p-TLC on SiO2 with CHCl3–MeOH–
28% aq. NH3 (46 : 5 : 0.5, v/v) to give 5 (8.0 mg, 57%).
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